Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2022-11-29 Major Shareholding Noti…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
General updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015, informing about the transfer of shares held by Ajooni Biotech Limited in another company. It is a notification about a shareholding transaction rather than a financial report or detailed filing. The content matches the description of a Major Shareholding Notification, as it reports a change in significant share ownership levels (15.23% share transfer). The document length is short and focused on this specific shareholding update, with no financial statements or other report content. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2022-11-29 English
Communication to shareholders as per Reg 30
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015, informing about the transfer of shares (share purchase agreement) by Ajooni Biotech Limited. It is an announcement related to a change in shareholding or capital structure, specifically about the transfer of shares representing 15.23% ownership in another company. The document is short (1447 characters) and is a notification of a transaction rather than a detailed financial report or audit. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share transfers.
2022-11-29 English
Outcome of committee meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India regarding the outcome of a Right Issue Committee meeting. It announces the approval of the Letter of Offer and related documents for a Rights Issue scheduled to open and close on specific dates. The content focuses on the approval and announcement of a capital raising event (Rights Issue), including offer price and entitlement ratio details. The document is short (2118 characters) and serves as an official announcement rather than a detailed report or financial statement. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-11-25 English
Record Date
Capital/Financing Update Classification · 100% confidence The document is an official communication from Ajooni Biotech Limited to the National Stock Exchange of India regarding the approval and schedule of a rights issue of equity shares. It details the terms, record date, issue price, and other specifics of the rights issue. The document references compliance with SEBI Listing Regulations and SEBI ICDR Regulations. It is an announcement about a capital raising event (rights issue) and not a financial report, earnings release, or other types of filings. The content fits the category of Capital/Financing Update (CAP) as it provides updates on the company's fundraising activity and capital structure changes.
2022-11-21 English
Outcome of committee meeting
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Ltd regarding compliance with SEBI Listing Regulations. It announces the outcome of a Rights Issue Committee meeting, specifying the record date and schedule for a rights issue of equity shares. The content focuses on capital raising activities and regulatory compliance related to a rights issue, without containing financial statements or detailed financial analysis. The document length is relatively short (2578 characters) and it serves as an official announcement of financing activity rather than a full financial report or detailed investor presentation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-11-21 English
General updates
Regulatory Filings Classification · 95% confidence The document is a short announcement from Ajooni Biotech Limited informing the National Stock Exchange of India about receiving the ZED certification from the Ministry of Micro, Small & Medium Enterprises, Government of India. It highlights the significance of the certification and the company's credentials but does not contain any financial data, detailed report, or regulatory filing. The document is under 5,000 characters and serves as an informational update rather than a formal report or filing. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2022-11-21 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.